AstraZeneca PLC

Registration Deadline:

02/21/2025

Submit Your Information

A securities class action has been filed in the USDC — C.D.CA. against AstraZeneca PLC (AZN) (“AstraZeneca” or the “Company”), on behalf of all those that purchased or otherwise acquired publicly traded AstraZeneca securities, between February 23, 2022, and December 17, 2024, both dates inclusive (the “Class Period”).

 

AstraZeneca [. . .] is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca’s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide.

 

The Complaint alleges that defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that:

 

(1) AstraZeneca engaged in insurance fraud in China;

(2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President being detained by Chinese law enforcement authorities;

(3) as a result, AstraZeneca understated its legal risks;

(4) the foregoing, once revealed, could materially harm AstraZeneca’s business activities in China; and

(5) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times, thereby harming investors.

 

If you purchased AstraZeneca securities, including call options, during the class period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information.”

 

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.